BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/78/0.1/21.06.24 | Market Closed - Boerse Frankfurt Warrants 11:33:23 31/05/2024 pm IST | ||
| 0.82 EUR | -19.61% |
|
| 1 month | +1.23% | ||
| 3 months | -17.17% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 0.82 | -19.61% |
| 30/24/30 | 1.02 | +12.09% |
| 29/24/29 | 0.91 | +5.81% |
| 28/24/28 | 0.86 | -12.24% |
| 27/24/27 | 0.98 | -.--% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 11:33 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM575G |
| ISIN | DE000VM575G8 |
| Date issued | 30/11/2023 |
| Strike | 78 $ |
| Maturity | 21/06/2024 (19 Days) |
| Parity | 10 : 1 |
| Emission price | 0.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.8 € |
|---|---|
| Lowest since issue | 0.28 € |
| Spread | 0.01 € |
| Spread % | 1.11% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
- Stock Market
- Warrants
- Warrant
